Redx Pharma Plc (LON:REDX)

Redx Pharma Plc (LON:REDX)


Share Price
5.47 p
Change
0.119 (2.22 %)
Market Cap
£6.92 m
Proactive Investors - Run By Investors For Investors

Redx Pharma Plc RNS Release

Share Purchase by Chairman


RNS Number : 0858M
Redx Pharma plc
25 April 2018
 

REDX PHARMA PLC

("Redx" or "the Company")

 

Share Purchase by Chairman

 

 

Alderley Park, 25 April 2018 Redx (AIM: REDX), the drug discovery and development company focused on cancer and fibrosis, announces that it has been notified that Iain Ross, Executive Chairman, has today acquired 150,000 Redx ordinary shares at a price of 11 pence per share.  Following this, Mr Ross will hold 600,000 ordinary shares in the Company, representing 0.47 per cent. of the issued share capital.

 

 

For further information, please contact:

Redx Pharma Plc

T: +44 1625 469 918

Iain Ross, Executive Chairman

 

 

 

Cantor Fitzgerald Europe (Nominated Advisor & Broker)

 T: +44 20 7894 7000

Phil Davies

 

 

 

WG Partners LLP (Joint Broker)

T: +44 20 3705 9330

Claes Spång/ Chris Lee/ David Wilson

 

 

 

FTI Consulting

T: +44 20 3727 1000

Simon Conway/Stephanie Cuthbert

 

 

About Redx Pharma Plc 

Redx is a UK biotechnology company whose shares are traded on AIM (AIM:REDX). Redx is focused on creating and developing first, or potentially best in class drugs, in specific areas of cancer and fibrosis that address significant unmet medical need. Redx has an in-house discovery team with proven world-class chemistry capabilities.

 

 



 

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014

1

Details of the person discharging managerial responsibilities/person closely associated

a.

Name

Iain Ross

2

Reason for notification

 

 

 

a.

Position/Status

Executive Chairman

b.

Initial notification/

Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Redx Pharma Plc

b.

LEI

213800HMS4EBXO589Y37

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrument

Identification Code

Ordinary Shares of 1p each


ISIN: GB00BSNB6S51

b.

Nature of the transaction

Purchase

c.

Price(s) and volume(s)

150,000

 

11 pence

d.

Aggregated information

- Aggregated Volume

- Price

N/A - Single Transaction

e.

Date of the transaction

25/04/18

f.

Place of the transaction

London Stock Exchange

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHUVVKRWVASURR

Redx Pharma Plc Timeline

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use